IRIS
BUONOMO, ANTONIO RICCARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.810
EU - Europa 3.653
NA - Nord America 3.646
SA - Sud America 603
AF - Africa 156
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12.880
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.446
SG - Singapore 2.533
RU - Federazione Russa 1.969
CN - Cina 1.242
IT - Italia 660
BR - Brasile 493
HK - Hong Kong 357
VN - Vietnam 329
DE - Germania 236
NL - Olanda 218
FI - Finlandia 123
CA - Canada 111
GB - Regno Unito 111
IN - India 80
KR - Corea 72
IE - Irlanda 70
FR - Francia 69
MX - Messico 59
ZA - Sudafrica 54
AR - Argentina 47
PL - Polonia 46
BD - Bangladesh 42
CI - Costa d'Avorio 35
AT - Austria 29
ES - Italia 27
JP - Giappone 26
SE - Svezia 25
EC - Ecuador 22
IQ - Iraq 21
ID - Indonesia 17
TR - Turchia 16
EG - Egitto 15
MA - Marocco 13
UA - Ucraina 13
LT - Lituania 12
CO - Colombia 11
AE - Emirati Arabi Uniti 10
AZ - Azerbaigian 8
CZ - Repubblica Ceca 8
PK - Pakistan 8
SA - Arabia Saudita 8
VE - Venezuela 8
CL - Cile 6
KE - Kenya 6
UZ - Uzbekistan 6
AU - Australia 5
BE - Belgio 5
CH - Svizzera 5
DZ - Algeria 5
JM - Giamaica 5
TH - Thailandia 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
ET - Etiopia 4
IR - Iran 4
MK - Macedonia 4
NP - Nepal 4
PE - Perù 4
PY - Paraguay 4
SV - El Salvador 4
TN - Tunisia 4
BG - Bulgaria 3
CR - Costa Rica 3
NZ - Nuova Zelanda 3
PH - Filippine 3
PR - Porto Rico 3
RS - Serbia 3
AL - Albania 2
CV - Capo Verde 2
HN - Honduras 2
HR - Croazia 2
JO - Giordania 2
KZ - Kazakistan 2
LB - Libano 2
LU - Lussemburgo 2
MG - Madagascar 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SO - Somalia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
DJ - Gibuti 1
DM - Dominica 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GM - Gambi 1
GY - Guiana 1
HT - Haiti 1
HU - Ungheria 1
IL - Israele 1
Totale 12.856
Salva come PNG Salva come JPEG
Città #
Singapore 1.246
Moscow 496
Ashburn 476
Hefei 421
Hong Kong 356
Beijing 318
Chandler 294
Santa Clara 214
Naples 210
Amsterdam 177
Los Angeles 169
Ho Chi Minh City 123
San Jose 115
Munich 101
New York 100
Millbury 81
Seoul 71
Hanoi 68
Dallas 65
São Paulo 63
Boston 61
Des Moines 61
Napoli 61
Nanjing 54
Redondo Beach 51
The Dalles 50
Buffalo 46
Boardman 45
Ottawa 45
Princeton 45
Seattle 42
Turku 42
Warsaw 39
Lawrence 35
Montreal 34
Rome 34
Orem 31
Johannesburg 29
Chicago 27
Frankfurt am Main 27
Houston 26
Nuremberg 26
Helsinki 25
Mexico City 25
Tokyo 25
Wilmington 23
Chennai 22
Denver 22
London 22
Poplar 22
Stockholm 22
Brooklyn 21
Milan 21
Atlanta 17
Phoenix 16
Querétaro 16
San Francisco 16
Shenyang 16
Da Nang 15
Nanchang 15
Düsseldorf 14
Washington 14
Toronto 13
Baghdad 12
Lappeenranta 12
Manchester 12
Rio de Janeiro 12
Guangzhou 11
Hebei 11
Jiaxing 11
Ankara 10
Dublin 10
Kochi 10
Vienna 10
Zhengzhou 10
Porto Alegre 9
Baku 8
Belo Horizonte 8
Caserta 8
Council Bluffs 8
Curitiba 8
Dhaka 8
Falkenstein 8
Fisciano 8
Guarulhos 8
Marseille 8
Pozzuoli 8
Boise 7
Brasília 7
Casablanca 7
Changsha 7
Charlotte 7
Haiphong 7
Hải Dương 7
Indiana 7
Ninh Bình 7
Bologna 6
Cairo 6
Campinas 6
Itajaí 6
Totale 6.792
Salva come PNG Salva come JPEG
Nome #
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 158
The discovery of sofosbuvir: a revolution for therapy of chronic hepatitis C 136
Successful treatment of post-surgical osteomyelitis caused by XDR Pseudomonas aeruginosa with ceftolozane/tazobactam monotherapy 136
Invasive Fungal Infections in Hospitalized Patients with COVID-19: A Non-Intensive Care Single-Centre Experience during the First Pandemic Waves 135
Casirivimab and Imdevimab for Pregnant Women Hospitalized for Severe Coronavirus Disease 2019 (COVID-19) 132
Clinical Features of Patients with Home Isolation Sars-Cov-2 Infection: A Multicenter Retrospective Study in Southern Italy 131
Hepatitis C screening in the Emergency Department of a large hospital in southern Italy: results of a pilot study 131
A Simple Non-Invasive Score Based on Baseline Parameters Can Predict Outcome in Patients with COVID-19 129
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 128
Efficacy of Molnupiravir in Reducing the Risk of Severe Outcomes in Patients with SARS-CoV-2 Infection: A Real-Life Full-Matched Case–Control Study (SAVALO Study) 128
A Novel Promising Therapeutic Option Against Hepatitis C Virus: An Oral Nucleotide NS5B Polymerase Inhibitor Sofosbuvir 126
Diabetes and COVID-19: The potential role of mTOR 125
mTOR Inhibitor Use Is Associated With a Favorable Outcome of COVID-19 in Patients of Kidney Transplant: Results of a Retrospective Study 123
A Simple Noninvasive Score Based on Routine Parameters can Predict Liver Cirrhosis in Patients With Chronic Hepatitis C 123
Prevalence and risk factors of erectile dysfunction in patients with hepatitis B virus or hepatitis C virus or chronic liver disease: Results from a prospective study 122
MK-5172 : a second-generation protease inhibitor for the treatment of hepatitis C virus infection. 121
Asunaprevir for hepatitis C: A safety evaluation 121
Post-mortem diagnosis of invasive pulmonary aspergillosis after alemtuzumab treatment for multiple sclerosis 121
Epidemiological and clinical features of syphilis in the 21st century: A seven-year observational retrospective study of outpatients 120
Nirmatrelvir/Ritonavir and Molnupiravir in the Treatment of Mild/Moderate COVID-19: Results of a Real-Life Study 120
Anti-HBc positivity was associated with histological cirrhosis in patients with chronic hepatitis C. 119
Does compulsory vaccination limit personal freedom? Ethical issues 119
COVID-19 chest CT and laboratory features of B.1.617.2 (Delta variant) vs B.1.1.7 (Alpha variant) surge: a single center case-control study 118
Concomitant Interferon-alfa and chemotherapy in hepatitis C and colorectal cancer: a case report 118
A survey on antibiotic therapy knowledge among physicians of a tertiary care and university hospital 116
Trends in Caesarean Section Rate According to Robson Group Classification among Pregnant Women with SARS-CoV-2 Infection: A Single-Center Large Cohort Study in Italy 115
Diagnostic Accuracy of PIVKA-II, Alpha-Fetoprotein and a Combination of both in Diagnosis of Hepatocellular Carcinoma in Patients Affected by Chronic HCV Infection 114
Pneumocystis jirovecii pneumonia in an immunocompetent patient recovered from COVID-19 114
Early combination of sotrovimab with nirmatrelvir/ritonavir or remdesivir is associated with low rate of persisting SARS CoV-2 infection in immunocompromised outpatients with mild-to-moderate COVID-19: a prospective single-centre study 112
COVID-19 Post-Exposure Evaluation (COPE) Study: Assessing the Role of Socio-Economic Factors in Household SARS-CoV-2 Transmission within Campania Region (Southern Italy) 112
Investigational direct-acting antivirals in hepatitis C treatment: The latest drugs in clinical development 112
Impact of an anti-infective screening and monitoring protocol together with infectious disease consultation in preventing infective adverse events in patients treated with anti-CD20/CD52 agents for multiple sclerosis 111
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study 111
Microbiota and hepatitis C virus in the era of direct-acting antiviral agents 110
Epilobium angustifolium L. extract with high content in oenothein B on benign prostatic hyperplasia: A monocentric, randomized, double-blind, placebo-controlled clinical trial 110
Prevalenza di infezioni da CMV, HHV-6 o EBV in bambini con disturbi dello spettro autistico. 110
Diabetes and SARS-CoV-2 Infection: The Potential Role of Antidiabetic Therapy in the Evolution of COVID-19 109
Risk Factors for Pneumocystis jirovecii Pneumonia in Non-HIV Patients Hospitalized for COVID-19: A Case-Control Study 109
Studio sulla conoscenza dell’antibioticoterapia tra i medici di un ospedale universitario di terzo livello 109
Central venous catheter related bloodstream infections in adult patients on home parenteral nutrition: Prevalence, predictive factors, therapeutic outcome 109
Update on infective complications in patients treated with alemtuzumab for multiple sclerosis: review and meta-analysis of real-world and randomized studies 108
Impact of oral antiviral therapy against HCV on gut microbiota. A prospective study 107
Human Platelet Antigen Genotypes As Predictors of Liver Cirrhosis In Patients With Hcv Chronic Infection 107
Discontinued drugs in 2012 - 2013: Hepatitis C virus infection 107
Vitamin D deficiency is a risk factor for infections in patients affected by HCV-related liver cirrhosis 107
Vein wall thickness and severity of pulmonary involvement due to sars n-cov2 virus infection 106
Correction: Efficacy of Nirmatrelvir/ritonavir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case–control study (SAVALO Study)(BMC Infect Dis., (2024), 24, 1434, 10.1186/s12879-024-10303-5) 106
Monoclonal Antibodies against SARS-CoV-2 Infection: Results from a Real-Life Study before the Omicron Surge 105
Ledipasvir : a novel synthetic antiviral for the treatment of HCV infection. 105
Efficacy and safety of a fixed dose combination tablet of asunaprevir + beclabuvir + daclatasvir for the treatment of Hepatitis C 105
Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrence: Results from an Italian real-life cohort (LINA cohort) 105
Sotrovimab in Solid Organ Transplant Patients With Early, Mild/Moderate SARS-CoV-2 Infection: A Single-center Experience 104
Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity—LINA cohort) 104
Daclatasvir: The First of a New Class of Drugs Targeted Against Hepatitis C Virus NS5A 103
Exposure to Varicella Zoster Virus is higher in children with autism spectrum disorder than in healthy controls. Results from a case-control study. 103
Beclabuvir for the treatment of hepatitis C 103
A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients 103
The serum-ascites vitamin D gradient (SADG): A novel index in spontaneous bacterial peritonitis 103
Efficacy of the "first wave" Direct Acting antivirals against HCV infection: results from the Italian LINA (Liver Network Activity) cohort 103
Seronegative occult HBV reactivation complicated with fulminant acute liver failure after rituximab for chronic inflammatory demyelinating polyneuropathy 103
Pneumocystis jirovecii Pneumonia in Non-HIV Patients Recovering from COVID-19: A Single-Center Experience 102
Human platelet antigen 3 genotype predicts platelet count in patients with HCV infection 102
Prevalence of HSV1/2 congenital infection assessed through genome detection on dried blood spot in individuals with autism spectrum disorders 102
Case Report: Discovery a Novel SARS-CoV-2 Variant in a Six-Months Long-Term Swab Positive Female Suffering From Non-Hodgkin Lymphoma 102
COVID-19 in patients with thymic epithelial tumors with or without Good's syndrome: a single-center retrospective study 101
Fecal microbiota transplantation for Clostridium difficile infection: Back to the future 101
Novel strategies for the management of bacterial and fungal infections in patients with liver cirrhosis: focus on new antimicrobials 101
Interferon-free regimens improve kidney function in patients with chronic hepatitis C infection 100
Current evidence on the management of hepatitis B in pregnancy 100
Vitamin D deficiency is an independent risk factor and is predictor of infections in patients affected by HCV-related liver cirrhosis 100
Bacterial and CMV pneumonia in a patient treated with alemtuzumab for multiple sclerosis 100
Invasive pulmonary aspergillosis and pulmonary tuberculosis in a patient treated with infliximab for Crohn's disease 100
Should SARS CoV-2 infection be considered an independent risk factor for Pneumocystis jirovecii pneumonia? Emerging data after two years of pandemic from a single center experience 99
Prevalence of Pneumocystis jirovecii Colonization in Non-Critical Immunocompetent COVID-19 Patients: A Single-Center Prospective Study (JiroCOVID Study) 99
A standardized polyphenol mixture extracted from poplar-type propolis for remission of symptoms of uncomplicated upper respiratory tract infection (URTI): A monocentric, randomized, double-blind, placebo-controlled clinical trial 99
COVID-19 prevention and multiple sclerosis management: The SAFE pathway for the post-peak 98
Risk of invasive fungal infections among patients treated with disease modifying treatments for multiple sclerosis: a comprehensive review 98
Monoclonal antibodies for mild-to-moderate COVID-19 in multiple sclerosis: A case series 96
Bulevirtide Treatment of Hepatitis Delta Virus Infection in a Kidney Transplant Recipient: A Case Report 96
Prevalence of herpes simplex virus 1 and 2 antibodies in patients with autism spectrum disorders. 96
Unsolved issues in the treatment of spontaneous peritonitis in patients with cirrhosis: Nosocomial versus community-acquired infections and the role of fungi 96
Outpatient Use of Monoclonal Antibodies Casirivimab and Imdevimab in Pregnancy for Mild-to-Moderate Coronavirus Disease 2019 95
Effect of Direct Antiviral Therapy Against HCV on CD4+ T Cell Count in Patients with HIV-HCV Coinfection 95
Correction to: Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study (Journal of Neurology, (2022), 269, 6, (3301-3307), 10.1007/s00415-022-11009-x) 95
Interferon-free therapies for chronic hepatitis C: toward a hepatitis C virus-free world? 95
Erectile dysfunction in patients with chronic viral hepatitis: a systematic review of the literature 94
Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection. 94
The therapeutic potential of new investigational hepatitis C virus translation inhibitors 94
Changing epidemiology of patients treated with direct acting antivirals for HCV and persistently high SVR12 in an endemic area for HCV infection in Italy: real-life 'LIver Network Activity' (LINA) cohort update results 94
Prevalence and titre of antibodies to cytomegalovirus and epstein-barr virus in patients with autism spectrum disorder. 93
Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg 93
Update on the Management of Surgical Site Infections 92
SARS-CoV-2 in Kidney Transplant Patients: A Real-Life Experience 92
Severe Vitamin D deficiency increases mortality among patients with liver cirrhosis regardless of the presence of HCC 91
Infections worsen prognosis of patients with cirrhosis irrespective of the liver disease stage 90
Treatment of Carbapenem-Resistant Acinetobacter baumannii in Real Life (T-ACI): A Prospective Single-Center Observational Study 89
Risk of opportunistic infections in patients treated with alemtuzumab for multiple sclerosis 88
Resolution of autoimmune thrombocytopenia associated with raltegravir use in an HIV-positive patient. 87
Efficacy and Safety of Sofosbuvir in Treatment of Chronic Hepatitis C: The Dawn of the a New Era. 87
Prevention of mother-to-child transmission of hepatitis B virus and hepatitis C virus. 87
Totale 10.753
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.458
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.458
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202172 0 0 0 0 0 0 8 4 18 19 11 12
2021/2022479 2 4 0 4 3 21 3 19 64 44 116 199
2022/2023858 85 60 23 50 99 107 18 74 120 176 32 14
2023/2024790 25 109 131 65 64 113 8 70 18 12 90 85
2024/20254.310 137 158 16 77 104 255 415 253 291 492 1.651 461
2025/20265.938 945 727 1.059 1.031 1.599 437 140 0 0 0 0 0
Totale 13.124